A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma

NCT00744991 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Cutaneous T-Cell Lymphoma

Interventions

DRUG: Enzastaurin

Sponsor

Eli Lilly and Company